The Neurodiagnostics Report
Table of Contents
1 Neurodiagnostic Markets
Sector Overview
Neurodiagnostics Industry Taxonomy
FDA Approval and Reimbursement of Diagnostics
Market Opportunities in Neurology and Psychiatry
Number of People impacted by Neurological and Psychiatric Disorders, WW and US
Neurology Markets and Emerging Diagnostics
Alzheimer's
Autism
Traumatic Brain Injury
Psychiatry Markets and Emerging Diagnostics
Depression
2 Neuroimaging
Medical Divisions of Fortune 500 Companies Dominate
Computed Tomography (CT)
Nuclear Medicine Imaging (PET, SPECT)
Electro-encephalography (EEG)
Magneto-encephalography (MEG)
Neurolens Open Source Brain Imaging Software
3 In Vitro Diagnostics
In Vitro Diagnostics Regulatory Landscape
Genetic Testing and Pharmacogenomics
Protein Biomarker Assays
Pattern Recognition in Diagnostics
4 Neuroinformatics
Databases
Neuroinformatics Data Storage
Paul Allen Brain Atlas Project
IBM Blue Brain Project
Diagnostic Software
5 Investing in Neurodiagnostics
Venture Capital Investment
Neurodiagnostic Venture Financings, Companies and Investors 2005-2011
Public Investment Activity and IPOs
Diagnostic Initial Public Offerings (IPOs), 2004 - 2011
Public Neurodiagnostic Related Companies, Stock Performance and Fundamentals
Merger and Acquisition Activity
6 Company Profiles
Neurodiagnostic Companies: Private
Neurodiagnostic Companies: Public
|
|
|